Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine
Authors
Keywords
-
Journal
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Volume 373, Issue 3, Pages 391-401
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Online
2020-03-27
DOI
10.1124/jpet.119.264507
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allele-Selective Knockdown of MYH7 Using Antisense Oligonucleotides
- (2020) Brian R. Anderson et al. Molecular Therapy-Nucleic Acids
- Cilantro leaf harbors a potent potassium channel–activating anticonvulsant
- (2019) Rían W. Manville et al. FASEB JOURNAL
- KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines
- (2019) Rían W. Manville et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia
- (2019) Edgard Verdura et al. JOURNAL OF MEDICAL GENETICS
- Gabapentin is a potent activator of KCNQ3 and KCNQ5 potassium channels
- (2018) Rian W Manville et al. MOLECULAR PHARMACOLOGY
- Direct neurotransmitter activation of voltage-gated potassium channels
- (2018) Rían W. Manville et al. Nature Communications
- Identification of a New de Novo Mutation Underlying Regressive Episodic Ataxia Type I
- (2018) Zeynep S. Karalok et al. Frontiers in Neurology
- Deconstruction of an African folk medicine uncovers a novel molecular strategy for therapeutic potassium channel activation
- (2018) Angele M. De Silva et al. Science Advances
- Molecular mechanisms underlying pimaric acid-induced modulation of voltage-gated K + channels
- (2017) Kazuho Sakamoto et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions
- (2017) Paola Imbrici et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- A recurrent mutation inKCNA2as a novel cause of hereditary spastic paraplegia and ataxia
- (2016) Katherine L. Helbig et al. ANNALS OF NEUROLOGY
- Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy
- (2016) Mark A. Corbett et al. NEUROLOGY
- De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy
- (2015) Steffen Syrbe et al. NATURE GENETICS
- New insights into the pathogenesis and therapeutics of episodic ataxia type 1
- (2015) Maria Cristina D’Adamo et al. Frontiers in Cellular Neuroscience
- Atomic basis for therapeutic activation of neuronal potassium channels
- (2015) Robin Y. Kim et al. Nature Communications
- Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene
- (2015) Maria C. D'Adamo et al. Frontiers in Physiology
- Arrhythmogenic KCNE gene variants: current knowledge and future challenges
- (2014) Shawn M. Crump et al. Frontiers in Genetics
- Voltage-gated potassium channels and the diversity of electrical signalling
- (2012) Lily Yeh Jan et al. JOURNAL OF PHYSIOLOGY-LONDON
- Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures
- (2011) Saeko Ishida et al. BRAIN RESEARCH
- Functional Analysis of the Kv1.1 N255D Mutation Associated with Autosomal Dominant Hypomagnesemia
- (2009) Jenny van der Wijst et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A missense mutation in the Kv1.1 voltage-gated potassium channel–encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia
- (2009) Bob Glaudemans et al. JOURNAL OF CLINICAL INVESTIGATION
- A novelKCNA1mutation associated with global delay and persistent cerebellar dysfunction
- (2009) Michelle K. Demos et al. MOVEMENT DISORDERS
- Refinement of the Binding Site and Mode of Action of the Anticonvulsant Retigabine on KCNQ K+ Channels
- (2008) W. Lange et al. MOLECULAR PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation